Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Insmed Incorporated - Common Stock (NQ: INSM )

76.98 +4.47 (+6.16%)
Streaming Delayed Price Updated: 1:17 PM EST, Jan 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 968,237
Open 72.92
Bid (Size) 76.89 (6)
Ask (Size) 76.98 (1)
Prev. Close 72.51
Today's Range 72.85 - 76.98
52wk Range 21.92 - 80.53
Shares Outstanding 115,246,666
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Goldman Sachs Sees High Merger Odds For This Large-Cap Biopharma In Trump 2.0 Era: Retail Has Been Alert
Insmed specializes in treatments for rare and serious diseases and is currently advancing its lead asset, brensocatib, a potential first-in-class therapy for bronchiectasis. 
Via Stocktwits
Topics Government
Exposures Political
How Is The Market Feeling About Insmed?
Via Benzinga

Performance

YTD
+10.05%
+10.05%
1 Month
+9.05%
+9.05%
3 Month
+6.50%
+6.50%
6 Month
+0.92%
+0.92%
1 Year
+169.82%
+169.82%

More News

Read More
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Here's How Much You Would Have Made Owning Insmed Stock In The Last 10 Years
Via Benzinga
1 Vanguard Index Fund to Buy to Beat the S&P 500 in 2025, According to a Wall Street Bank
Via The Motley Fool
Topics Stocks
Exposures US Equities
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
How Is The Market Feeling About Insmed?
Via Benzinga
Demystifying Insmed: Insights From 7 Analyst Reviews
Via Benzinga
Insmed's Options: A Look at What the Big Money is Thinking
Via Benzinga
1 Vanguard Index Fund May Beat the S&P 500 by 100% in the Next Few Years, According to a Wall Street Analyst
Via The Motley Fool
Topics Stocks
Exposures US Equities
Energizer, C3.ai, Insmed And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Topics Government
Exposures Political
A Glimpse of Insmed's Earnings Potential
Via Benzinga
Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today
Via Benzinga
Peering Into Insmed's Recent Short Interest
Via Benzinga
Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much You Would Have Made Owning Insmed Stock In The Last 10 Years
Via Benzinga
(INSM) - Analyzing Insmed's Short Interest
Via Benzinga
Here's How Much $1000 Invested In Insmed 10 Years Ago Would Be Worth Today
Via Benzinga
$1000 Invested In Insmed 10 Years Ago Would Be Worth This Much Today
Via Benzinga
NASDAQ:INSM Shows Potential for a Breakout.
Via Chartmill
Meta Stock Leads 5 Names Near Buy Points As Market Bounces
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Good technical signals and a possible breakout for INSMED INC.
Via Chartmill
$100 Invested In Insmed 5 Years Ago Would Be Worth This Much Today
Via Benzinga
INSM Stock Earnings: Insmed Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.